NCT04055870View on ClinicalTrials.gov

Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Chronic HepaticLiver Diseases
Interventions
PROCEDURE

EUS-guided liver biopsy at MDMC

Endoscopic ultrasound (EUS) guided liver biopsy sampling is emerging as an alternative to the aforementioned approaches that offers several advantages, including decreased sampling variability and procedure-related complications.

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT04055870 - Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy | Biotech Hunter | Biotech Hunter